Skip to content
Research Article Open access CC BY 4.0

Highly Sensitive C Reactive Protein as a Predictor of in Hospital Outcome in Patients with Acute Coronary Syndrome

Amr Hamama Hussen, Ahmed Farok Alaraag, Mohamed Ahmed Abdalaal, Ayman Mohamed Alsaed

Cardiology and Angiology: An International Journal · pp. 113–119 · Published 8 Jun 2022

10.9734/ca/2022/v11i430213

Abstract

Background: C-reactive (CRP) protein is a well-studied inflammatory factor whose prognostic value in cardiovascular diseases in recent years has become increasingly important. Assesses of prognostic value of highly sensitive C-reactive protein (hs-CRP) in patients with acute coronary syndrome (ACS) wasthe aim of this work. Methods: This observational research was conducted on 50 individuals had ACS admitted to CCU and indicated for invasive coronary angiography. Cases were classified in 2 groups depending on the level of hs-CRP: group A included (14) cases with hs-CRP > (2) and group B involved (36) cases with hs-CRP ≥ (2). All patients were subjected to: laboratory investigations (creatinine, urea, aspartate aminotransferase (AST), alanine amino transferase (ALT), troponin, creatine kinase myocardial band (CKMB), hs-CRP, HbA1C, lipid profile, twelve lead surface ECG, echocardiography and coronary angiography. Results: Total cholesterol, LDL, HDL and triglyceride were significantly higher in group B compared to group A(P=0.001). Stent implantation was significantly higher in group 2 compared to group 1 (P=0.040) Conclusions: There were correlation between hs CRP and lipid profile as a risk factor and there was no correlation between in hospital outcome and hs CRP in ACS patients due to small sized study.

Highly sensitive c reactive protein hospital outcome acute coronary syndrome

References (23)

  1. 1 C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis [DOI]
  2. 2 Targeting C-reactive protein for the treatment of cardiovascular disease [DOI]
  3. 3 Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data [DOI]
  4. 4 Clinical Relevance of C-Reactive Protein During Follow-Up of Patients With Acute Coronary Syndromes in the Aggrastat-to-Zocor Trial [DOI]
  5. 5 C-reactive protein is a mediator of cardiovascular disease [DOI]
  6. 6 C-reactive protein elevation and disease activity in patients with coronary artery disease [DOI]
  7. 7 Prognostic Utility of ApoB/AI, Total Cholesterol/HDL, Non-HDL Cholesterol, or hs-CRP as Predictors of Clinical Risk in Patients Receiving Statin Therapy After Acute Coronary Syndromes [DOI]
  8. 8 Prognostic value of C-reactive protein levels within six hours after the onset of acute myocardial infarction [DOI]
  9. 9 Clinical Utility of C-Reactive Protein Measured at Admission, Hospital Discharge, and 1 Month Later to Predict Outcome in Patients With Acute Coronary Disease [DOI]
  10. 10 C-Reactive Protein and Heart Failure after Myocardial Infarction in the Community [DOI]
  11. 11 C-reactive protein levels predict systolic heart failure and outcome in patients with first ST-elevation myocardial infarction treated with coronary angioplasty [DOI]
  12. 12 Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide [DOI]
  13. 13 Effects of statins on inflammation in patients with acute and chronic coronary syndromes [DOI]
  14. 14 Elevated C-reactive protein in acute coronary syndrome presentation is an independent predictor of long-term mortality and heart failure [DOI]
  15. 15 Independent prognostic value of C-reactive protein and coronary artery disease extent in patients affected by unstable angina [DOI]
  16. 16 Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction. The Framingham Heart Study [DOI]
  17. 17 Value of C-Reactive Protein in Predicting Left Ventricular Remodelling in Patients with a First ST-Segment Elevation Myocardial Infarction [DOI]
  18. 18 Soluble CD40L: risk prediction after acute coronary syndromes [DOI]
  19. 19 Usefulness of C-reactive protein as a marker of early post-infarct left ventricular systolic dysfunction [DOI]
  20. 20 Exposure to Parental Smoking in Childhood is Associated with High C-Reactive Protein in Adulthood: The Cardiovascular Risk in Young Finns Study [DOI]
  21. 21 C-reactive protein as a marker for acute coronary syndromes [DOI]
  22. 22 Evaluation of C-reactive protein, fibrinogen and antithrombin-III as risk factors for coronary artery disease.
  23. 23 Arteriosclerosis, Thrombosis, and Vascular Biology [DOI]

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

37

Page views

0

PDF downloads

8

Outbound clicks

0

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.